NYU Langone Hospital – Brooklyn is a full-service, 450-bed academic teaching hospital in the Sunset Park neighborhood of Brooklyn, New York City. Formerly named NYU Lutheran Medical Center, it functions as the hub of Lutheran Healthcare, which itself is part of the larger NYU Langone Health.

There are 450 beds in NYU Langone Hospital - Brooklyn.

During the past decade, NYU Langone Hospital - Brooklyn conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 4 clinical trials were completed, i.e. on average, 18.2% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 2 clinical trials were completed. i.e. 13.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "NYU Langone Hospital - Brooklyn" #1 sponsor was "NYU Langone Health" with 7 trials, followed by "Alliance for Clinical Trials in Oncology" with 2 trials sponsored, "NoNO Inc." with 2 trials sponsored, "Vericel Corporation" with 2 trials sponsored and "Albert Einstein College of Medicine" with 2 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "NYU Langone Hospital - Brooklyn" #1 collaborator was "National Cancer Institute (NCI)" with 4 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 4 trials as a collaborator, "Medical University of South Carolina" with 3 trials as a collaborator, "University of Cincinnati" with 3 trials as a collaborator and "University of Calgary" with 2 trials as a collaborator. Other collaborators include 32 different institutions and companies that were collaborators in the rest 42 trials.

According to Clinical.Site data, the most researched conditions in "NYU Langone Hospital - Brooklyn" are "Stroke" (5 trials), "Breast Cancer" (3 trials), "Covid19" (2 trials), "Stroke, Acute" (2 trials) and "Acid Sphingomyelinase Deficiency" (1 trials). Many other conditions were trialed in "NYU Langone Hospital - Brooklyn" in a lesser frequency.

Most popular intervention types in "NYU Langone Hospital - Brooklyn" are "Drug" (13 trials), "Other" (8 trials), "Procedure" (5 trials), "Behavioral" (4 trials) and "Device" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Aspirin" (3 trials), "Apixaban" (2 trials), "whole breast irradiation" (2 trials) and "Alteplase" (1 trials). Other intervention names were less common.

The vast majority of trials in "NYU Langone Hospital - Brooklyn" are 29 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are 16 active trials in "NYU Langone Hospital - Brooklyn". 1 are not yet recruiting, 9 are recruiting, 5 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 10 completed trials in NYU Langone Hospital - Brooklyn, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in NYU Langone Hospital - Brooklyn, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 9 trials that are defined as “Not Applicable".